BridgeMD

Sign in

Occlusion clinical trials

Explore recruiting occlusion clinical trials.

Recruiting occlusion studies right now

Study details & eligibility ClinicalTrials.gov record

Study details & eligibility ClinicalTrials.gov record

Study details & eligibility ClinicalTrials.gov record

Study details & eligibility ClinicalTrials.gov record

Study details & eligibility ClinicalTrials.gov record

Study details & eligibility ClinicalTrials.gov record

Study details & eligibility ClinicalTrials.gov record

Study details & eligibility ClinicalTrials.gov record

Study details & eligibility ClinicalTrials.gov record

Study details & eligibility ClinicalTrials.gov record

Study details & eligibility ClinicalTrials.gov record

Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Occlusion trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

Antiplatelet therapy after successful percutaneous coronary intervention for chronically occluded coronary artery: A prospective, multicentre, randomized study comparing two durations of dual antiplatelet therapy

France

Therapeutic confirmatory (Phase III) EU CTIS Study details

Optimal Antiplatelet Treatment to Achieve Stroke Avoidance and Fall in Bleeding Events following Left Atrial Appendage Closure – Chronic Kidney Disease (SAFE LAAC CKD). Comparative Health Effectiveness Ancillary Study – PILOT

Poland

Therapeutic use (Phase IV) EU CTIS Study details

Induced hypertension in acute PRogrESsive perforating artery Stroke Using peripheral dilute noREpinephrine

France

Therapeutic confirmatory (Phase III) EU CTIS Study details

Intra-Arterial thrombolysis after SUCCESSful angiographic recanalization in acute large vessel occlusion stroke of the anterior circulation: the IA-SUCCESS multicenter, randomized clinical trial

France

Therapeutic confirmatory (Phase III) EU CTIS Study details

Anticoagulant Regimens Given to achieve thrombus regression and reduce clinical Outcomes among patients with Non device-related intra-cardiac thrombus: a randomized Assessment Under direct oral anticoagulant and vitamin K antagonist Therapy – the ARGONAUT trial

France

Therapeutic confirmatory (Phase III) EU CTIS Study details

Extending the time window for Tenecteplase by Effective RecanalizatioN of bAsilar artery occLusion in patients with POSTerior circulation stroke (POST ETERNAL)

France

Therapeutic confirmatory (Phase III) EU CTIS Study details

Occlusion trials by city

Occlusion in Toronto Occlusion in Vancouver Occlusion in Montreal Occlusion in Calgary Occlusion in Edmonton Occlusion in Ottawa Occlusion in Winnipeg Occlusion in Quebec City Occlusion in Hamilton Occlusion in Kitchener Occlusion in London Occlusion in Halifax Occlusion in New York Occlusion in Los Angeles Occlusion in Chicago Occlusion in Houston